(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Bio-Path Holdings Reports First Quarter 2018 Financial Results

May 16, 2018

Conference Call to be Held Today at 8:30 A.M. ET

Bio-Path Holdings to Announce First Quarter 2018 Financial Results on May 16, 2018

May 09, 2018

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer...

Performance

More News

Pre-Clinical Data Demonstrating Promising Potential of Prexigebersen as Treatment for Solid Tumors in Gynecologic Malignancies Presented at American Association for Cancer Research Annual Meeting

April 18, 2018

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2017 Financial Results on April 3, 2018

March 27, 2018

Bio-Path Holdings Announces 1-for-10 Reverse Stock Split

February 08, 2018

Bio-Path Holdings to Present at the BIO CEO & Investor Conference

February 05, 2018

Bio-Path Holdings Appoints Paul Aubert to its Board of Directors

February 05, 2018

Pre-Market Technical Scan on Drug Delivery Equities -- Bio-Path, Alkermes, PetMed Express, and Valeant Pharma

January 31, 2018

Bio-Path Holdings Provides Clinical Update and 2018 Business Outlook

December 29, 2017

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH)

December 15, 2017

Mid-Day Market Update: Sears Hometown and Outlet Stores Falls Following Q4 Results; Bio-Path Shares Surge

April 19, 2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.